Search Results for agency_names:"Health and Human Services Department"

The National Advisory General Medical Sciences Council will hold a closed virtual meeting on May 22, 2025, from 1:30 p.m. to 2:00 p.m. This meeting, organized by the National Institute of General Medical Sciences of the National Institutes of Health, will focus on reviewing and evaluating grant applications. The meeting will be closed to protect confidential information, including trade secrets and personal data related to the grant applications. Additional meeting details, including the agenda, will be available on the institute's website.

The Centers for Medicare & Medicaid Services (CMS) is inviting public comments on its plan to collect information from the public under the Paperwork Reduction Act of 1995. This notice is published as part of a required procedure before seeking approval from the Office of Management and Budget for each information collection. Among the items addressed are Medicare Health Outcomes Survey, Community Mental Health Center Cost Report, the Request For Termination of Premium-Hospital and/or Supplementary Medical Insurance, and the Appointment of Representative form. CMS seeks feedback on the necessity and utility of these information collections, as well as suggestions for improving their quality and minimizing the burden they impose. Public comments are due by April 6, 2021, and can be submitted electronically or via regular mail.

The Food and Drug Administration (FDA) has issued an order permanently banning John Warrington Kosolcharoen from working with companies that have approved or pending drug product applications. This decision resulted from his felony conviction for fraudulently selling an unapproved stem cell product, ReGen, and making misleading claims about its safety and effectiveness. Mr. Kosolcharoen was given the chance to challenge the debarment but did not respond in the provided timeframe, leading to a waiver of his right to a hearing on the decision. During his debarment, any business that employs him for related services could also face penalties.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development announced a closed meeting scheduled for April 17, 2025. The meeting will run from 10:00 a.m. to 5:00 p.m. and will be held virtually. It is organized to review and evaluate grant applications related to pregnancy, perinatology, and pediatrics. The discussions will include sensitive information, such as confidential trade secrets and personal information, hence the closure to the public.

The Centers for Disease Control and Prevention (CDC) is seeking approval from the Office of Management and Budget (OMB) for a data collection project on childhood experiences and health equity among young adults in the U.S. The project aims to study how adverse and positive childhood experiences impact health outcomes, especially for young adults from marginalized communities. The study will involve surveying 6,000 young adults aged 18 to 24 and will collect data on their past experiences and health status. The study intends to improve the understanding of the connection between childhood experiences and health and will look at broader social and community factors that affect these outcomes.

The Office of Planning, Research, and Evaluation (OPRE) in the Administration for Children and Families (ACF) is looking for public comments on a new data collection effort called the Well-Being Storytelling Exhibit. This project is part of a larger study, called the NextGen Project, which aims to understand how people with low incomes can find and maintain jobs. Participants will use photos to share their experiences of well-being, which will then be analyzed and used to create an exhibit. The ACF seeks feedback on the necessity and impact of this information collection by February 24, 2025.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel to review grant applications. This virtual meeting will take place on February 24-25, 2025, from 11:00 a.m. to 5:00 p.m. EST. The meeting is closed to protect sensitive information, such as trade secrets and personal data, in compliance with federal regulations. Contact Dan Hartley at the CDC for more information.

The U.S. Department of Health and Human Services (HHS) announced new guidelines for the transplantation of organs from donors with HIV under the HOPE Act. These updated rules state that kidney and liver transplants from HIV-positive donors no longer need to follow specific research criteria if both donor and recipient have HIV. However, transplants involving other organs from HIV-positive donors still require an IRB-approved research protocol. The changes aim to enhance the understanding of organ transplants from HIV-positive donors while ensuring recipient safety and increasing organ access for patients with HIV.

The Food and Drug Administration (FDA) is inviting industry organizations to participate in selecting nonvoting representatives for the Patient Engagement Advisory Committee, which discusses the use and regulation of medical devices. These nonvoting representatives can be nominated either by the organizations or through self-nomination and should be experienced in fields related to medical devices. Organizations interested in participating must notify the FDA by January 29, 2025, and nominations should be submitted by the same date. The FDA is particularly looking for individuals with expertise in areas like cybersecurity, digital health, patient engagement, and health equity.

The National Diabetes and Digestive and Kidney Diseases Advisory Council is holding a meeting on May 14-15, 2025. This meeting, organized by the National Institutes of Health, will be open to the public during certain sessions, while other parts will be closed to protect confidential information. The agenda includes discussions, with time dedicated to reviewing grant applications and evaluating subcommittee reports. For participating or requiring special assistance, attendees should contact Karl F. Malik, Ph.D.